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Abstract
OBJECTIVE—We examined surveillance data to describe the epidemiology of tuberculosis (TB) 
among healthcare workers (HCWs) in the United States during the period 1995–2007.
DESIGN—Cross-sectional descriptive analysis of existing surveillance data.
SETTING AND PARTICIPANTS—TB cases reported to the Centers for Disease Control and 
Prevention from the 50 states and the District of Columbia from 1995 through 2007.
RESULTS—Of the 200,744 reported TB cases in persons 18 years of age or older, 6,049 (3%) 
occurred in individuals who were classified as HCWs. HCWs with TB were more likely than other 
adults with TB to be women (unadjusted odds ratio [95% confidence interval], 4.1 [3.8–4.3]), be 
foreign born (1.3 [1.3–1.4]), have extrapulmonary TB (1.6 [1.5–1.7]), and complete TB treatment 
(2.5 [2.3–2.8]).
CONCLUSIONS—Healthcare institutions may benefit from intensifying TB screening of HCWs 
upon hire, especially persons from countries with a high incidence of TB, and encouraging 
treatment for latent TB infection among HCWs to prevent progression to TB disease.
Since the early 1990s, outbreaks of tuberculosis (TB) and multidrug-resistant TB in various 
medical settings have demonstrated patient-to-healthcare worker (HCW) transmission of 
Mycobacterium tuberculosis,1-4 and other investigations have suggested that HCWs with 
untreated latent TB infection (LTBI) can later experience progression to TB disease, which 
can cause workplace exposure to patients and other HCWs.5,6 The extent of occupational 
risk of TB for HCWs varies according to many factors, including prevalence of TB in the 
patient population, immunocompetency of the HCW, and effectiveness of infection control 
measures in the healthcare setting.7
The objective of this analysis was to examine surveillance data and describe the 
epidemiology of TB among HCWs in the United States during the period 1995–2007. 
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Additional goals were to compare demographic characteristics and treatment outcomes of 
reported TB cases among HCWs and other adults and to compare US-born and foreign-born 
HCWs.
METHODS
This study describes new analyses of existing data routinely submitted to the Centers for 
Disease Control and Prevention through the National Tuberculosis Surveillance System. 
These data are collected for the purposes of disease surveillance and not human subject 
research that requires ethical institutional board review. TB cases were reported by the 50 
states and the District of Columbia. Data were collected on a standardized form that 
included demographic, laboratory, clinical, and treatment outcome information.
We calculated the proportion of TB cases reported during 1995–2007 that occurred in 
persons 18 years of age or older whose occupations were categorized as “healthcare 
worker.” Data for treatment outcomes were analyzed only through 2005 to provide a 2-year 
period to complete reporting. To calculate an annual TB incidence rate among HCWs, we 
used the US Census Bureau Current Population Survey’s estimate for the denominator of 
HCWs in the United States for 2003–2007.8 Estimated numbers of HCWs in the United 
States were not available before 2003.
Persons were considered to be foreign born if the reported country of birth was outside the 
United States or its jurisdictions in the Pacific and Caribbean. Method of TB treatment was 
recorded as (i) directly observed therapy (DOT), (ii) self-administered therapy, (iii) a 
combination of self-administered therapy and DOT, or (iv) unknown. DOT, an adherence-
enhancing strategy in which a HCW or other trained person watches a patient swallow each 
dose of medication, is the standard care for all patients with TB disease and is a preferred 
option for patients treated for LTBI in the United States, when feasible.9-11 Persons were 
classified as having a previous diagnosis of TB if they had verified TB in the past, had 
completed TB therapy, or were lost to supervision for more than 12 months and had verified 
TB again. The proportion of human immunodeficiency virus (HIV)–infected persons was 
calculated as a percentage of the total number of persons with test results reported (ie, 
negative, positive, or indeterminate). The number of persons documented as having refused 
an HIV test was also reported; others were classified as HIV status unknown (ie, HIV test 
not offered or result not reported).
Unadjusted odds ratios (uORs) were used to compare characteristics of HCWs who had TB 
with those of other adults who had TB and to compare characteristics of US-born HCWs 
who had TB with characteristics of foreign-born HCWs who had TB. Data were analyzed 
with SAS for Windows, version 9.1 (SAS Institute), and Microsoft Excel 2003 (Microsoft).
RESULTS
During the period 1995–2007, of the 200,744 TB cases involving patients 18 years of age or 
older, 6,049 (3%) were classified as HCWs (mean of 429 HCWs with TB per year). Using 
the US Census Bureau population estimates for HCWs for 2003–2007 (ie, an annual average 
of 1.8 million male and 7.0 million female US-born HCWs and 400,000 male and 1.1 
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million female foreign-born HCWs),8 the estimated overall annual incidence of TB for 
HCWs was 4.2 cases per 100,000 population (range, 3.8–4.6), similar to the overall national 
TB case rate of 4.4–5.1 cases per 100,000 population during the same time period.12 
However, the estimated annual incidence of TB among foreign-born HCWs was 
approximately 10 times higher than the incidence among US-born HCWs. Among male 
HCWs, the TB incidence rate was 2.3 cases per 100,000 US-born persons and 21.4 cases per 
100,000 foreign-born persons; among female HCWs, the TB incidence rate was 1.6 cases 
per 100,000 US-born persons and 16.6 cases per 100,000 foreign-born persons. Nationally, 
the TB case rate ranged between 20.7 cases and 23.5 cases per 100,000 foreign-born persons 
during 2003–2007.12
HCWs Who Had TB Compared with Other Adults Who Had TB
Characteristics of persons with TB according to HCW status are summarized in Table 1. 
Compared with other adults, HCWs were more likely to be women (uOR, 4.1 [95% 
confidence interval (CI), 3.8–4.3]), be foreign born (uOR, 1.3 [95% CI, 1.3–1.4]), have 
extrapulmonary TB (uOR, 1.6 [95% CI, 1.5–1.7]), complete TB treatment (uOR, 2.5 [95% 
CI, 2.3–2.8]), and have a reported HIV test result (uOR, 1.2 [95% CI, 1.1–1.2]). Among 
cases with reported HIV test results, fewer HCWs (13%) than other adults (20%) were HIV 
infected.
Clinical features of TB were similar among HCWs and other adults who had TB. Of those 
with reported initial drug-susceptibility results, HCWs had slightly higher percentages of 
isoniazid monoresistant TB (10% compared with 8% of other adults) and multidrug-resistant 
TB (2% compared with 1%); these differences were not statistically significant. Fewer 
HCWs (34%) were reported to have received all doses of TB medication by DOT, compared 
with 47% of other adults with TB (Table 1).
Foreign-Born HCWs Who Had TB Compared with US-Born HCWs Who Had TB
Of the 6,049 HCWs reported to have TB during those 13 years, 3,302 (55%) were foreign 
born. Of those, 67% were women, and 56% were Asian (Tables 1 and 2) From 1995 through 
2007, the proportion of foreign-born HCWs with TB increased from 42% to 71%. 
Meanwhile, among all TB cases, the proportion of cases among foreign-born persons 
increased annually from 35% to 58%.12
Compared with US-born HCWs who had TB, foreign-born HCWs who had TB were more 
likely to have isoniazid monoresistant TB (uOR, 2.1 [95% CI, 1.7–2.7]), have 
extrapulmonary TB (uOR, 1.5 [95% CI, 1.3–1.7]), and complete TB treatment (uOR, 1.3 
[95% CI, 1.1–1.6]; Table 2).
The top 3 countries of birth for foreign-born HCWs with TB in the United States were 
Philippines (32%), India (15%), and Haiti (6%), which represented 53% of all foreign-born 
HCWs with TB (Figure 1), whereas only 21% of other foreign-born adults with TB were 
from those 3 countries combined. In contrast, during this time period, the top countries of 
birth for all foreign-born persons with TB in the United States were Mexico (24%), 
Philippines (11%), and Vietnam (10%).12 The median number of years that foreign-born 
HCWs had resided in the United States was 7 (range, 0–64). Approximately 7% of foreign-
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born HCWs received a diagnosis of TB within 6 months of arrival to the United States; 18% 
received a diagnosis within the first year after arrival, 25% within 2 years after arrival, and 
43% within 5 years after arrival. In stratified analysis comparing foreign-born Asian HCWs 
with other foreign-born HCWs, extrapulmonary TB was reported for 46% of foreign-born 
Asian HCWs, compared with 23% of other foreign-born HCWs.
DISCUSSION
Although the rate of TB among HCWs was similar to the national rate, consequences in the 
workplace can be severe when HCWs have TB because of the vulnerable populations that 
they serve. These findings enable additional understanding of TB among HCWs in the 
United States and highlight the importance of maintaining a high index of suspicion for TB 
disease, especially among foreign-born workers, and of providing interventions to diagnose 
and treat LTBI among HCWs.
Despite the 2005 estimate that only 15% of HCWs in the United States were foreign born,13 
the estimated annual incidence of TB was approximately 10 times higher among foreign-
born HCWs during 2003–2007 than among US-born HCWs, and more than half of all TB 
cases among HCWs during 1995–2007 occurred among foreign-born persons, which reflects 
the growing number of TB cases among foreign-born persons in the United States.12,14
Overall, during this time period, 11%–12% of foreign-born persons with TB were from 
Philippines. That percentage is in contrast to the 32% of foreign-born Filipino HCWs in this 
analysis, although consistent with the high proportion of foreign-born HCWs in the United 
States from Philippines.15,16 In 2000, almost 40% of internationally trained nurses in the 
United States were Filipino.16 In 2005, Philippines reported a TB incidence rate of 291 cases 
per 100,000 persons.17
Findings of our stratified analysis were also consistent with several studies that suggested 
that, compared with the general population, foreign-born persons, including HCWs, and 
specifically South Asian HCWs, were more likely to have extra-pulmonary TB than 
pulmonary TB.18-21
The findings in this report are subject to a number of limitations. Seven percent of the 1995–
2007 TB cases had missing data for occupation, and data were incomplete for other 
variables; HIV test results and treatment outcomes were missing for 37% and 8% of all 
HCWs, respectively (Table 1). However, completeness of reported TB data improved 
throughout the study period. For example, in 1995, 45% of all reported TB cases were 
missing information on HIV status; in 2007, 23% had missing HIV data. Also, for the years 
included in this analysis, the National TB Surveillance System did not collect the specific 
occupation, duration of employment in healthcare, or type of healthcare facility, nor did it 
collect previous diagnosis or treatment of LTBI.
In 2009, the National TB Surveillance System was modified to include LTBI history and, for 
foreign-born individuals, immigration status. This additional information could provide a 
better understanding of which interventions may improve diagnosis and treatment of LTBI 
among foreign-born HCWs before or soon after entry into the United States. In general, only 
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individuals entering the United States as immigrants or refugees are subject to a TB 
screening before entry.22 Of the foreign-born HCWs in this analysis, 25% received a 
diagnosis of TB within 2 years after arrival to the United States, which suggests that 
infection was acquired before entry rather than within the United States, which is a finding 
consistent with other studies.23,24
According to the reported data, HCWs were less likely than other adults with TB to have 
received all doses of treatment by DOT. DOT has multiple benefits, including maximizing 
the likelihood of treatment completion, preventing development of drug-resistant disease, 
and providing an opportunity to identify possible adverse effects of the medication. 
Providing DOT for HCWs at their work site has been an effective option for ensuring HCWs 
complete treatment for TB disease and, when possible, for LTBI.5,10 Identifying and treating 
LTBI is critical to preventing TB disease in this occupational group, but HCWs appear to be 
less likely to accept treatment for LTBI.25-27
Healthcare institutions, especially those associated with a high risk for TB exposure,10 may 
benefit from an intensified approach to TB education and screening of HCWs upon hire, 
particularly foreign-born workers, and from encouraging completion of treatment for LTBI, 
if indicated. Such strategies have been associated with cost savings.28 National guidelines 
recommend that HCWs who may be exposed to TB at the workplace be screened for TB 
disease symptoms and receive a tuberculin skin test or an interferon γ release assay blood 
test for TB infection annually.10 Strengthening TB prevention and control in healthcare 
settings will protect HCWs from TB, which will in turn protect patients and the community 
and further our progress toward the goal of TB elimination in the United States.
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Top 10 countries of birth of foreign-born healthcare workers who had tuberculosis in the 
United States, 1995–2007 (n = 3,302). *“Other” includes Kenya (2%), Vietnam (2%), China 
(2%), Ethiopia (2%), Peru (2%), and others.
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TABLE 1
Characteristics of Patients with Tuberculosis (TB), by Healthcare Worker (HCW) Status, among Individuals 








Female sex 4,195 (69) 69,661 (36)
Mean/median age at diagnosis, years 41/40 49/47
Age at diagnosis range, years 18–91 18–112
Age group, years
 18–35 2,322 (38) 54,798 (28)
 36–54 2,774 (46) 68,135 (35)
 ≥55 953 (16) 71,762 (37)
Birth country
 United States 2,736 (45) 101,382 (52)
 Othera 3,302 (55) 92,491 (48)
 Unknown 11 (<1) 822 (<1)
TST result at time of TB diagnosisb 4,724 (78) 138,173 (71)
 Positive 4,175/4,724 (88) 109,513/138,173 (79)
 Negative 549/4,724 (12) 28,660/138,173 (21)
Culture positive for Mycobacterium tuberculosis 4,829 (80) 162,718 (84)
Site of disease
 Pulmonary TB only 3,803 (63) 142,471 (73)
 Extrapulmonary TB only 1,766 (29) 36,700 (19)
 Both pulmonary and extrapulmonary TB 477 (8) 15,457 (8)
Findings among patients with any pulmonary TB
 Positive acid-fast bacilli sputum smear result 1,698/4,280 (40) 75,135/157,928 (48)
 Positive cavitary chest radiograph findingsc 1,053/4,280 (25) 43,313/157,928 (27)
Drug resistanced 4,708 (78) 157,213 (81)
 Isoniazid monoresistance 461/4,708 (10) 12,094/157,213 (8)
 Multidrug resistance 89/4,708 (2) 1,968/157,213 (1)
HIV test result reportede 3,331 (55) 99,621 (51)
 HIV positive 430/3,331 (13) 20,392/99,621 (20)
Refused HIV test 479 (8) 11,394 (6)
HIV test not offered, result unknown, or not reported 2,239 (37) 83,680 (43)
No previous diagnosis of TB 5,817 (96) 182,244 (94)
Postmortem diagnosis of TB 52 (<1) 5,893 (3)
Excessive alcohol use 215 (4) 30,461 (16)
Injection or noninjection drug use 131 (2) 17,146 (9)
Incarceration at time of diagnosis 23 (<1) 7,674 (4)
Method of TB treatmentf





















 Directly observed therapy 1,792/5,233 (34) 79,679/170,478 (47)
 Self-administered therapy 2,071/5,233 (40) 39,907/170,478 (23)
 Both directly observed and self-administered therapy 1,237/5,233 (24) 41,661/170,478 (24)
 Unknown 133/5,233 (3) 9,231/170,478 (5)
Treatment outcomef
 Completed therapy 4,745/5,233 (91) 135,062/170,478 (79)
 Did not complete therapy 488/5,233 (9) 35,416/170,478 (21)
  Moved 98/5,233 (2) 5,133/170,478 (3)
  Lost to follow-up 62/5,233 (1) 4,225/170,478 (2)
  Died 134/5,233 (3) 15,420/170,478 (9)
  Uncooperative/refused 44/5,233 (1) 1,114/170,478 (1)
  Other/unknown 150/5,233 (3) 9,524/170,478 (6)
NOTE. Data are no. (%) of persons with TB, unless otherwise indicated. Sum of percentages may not equal 100% due to rounding. HIV, human 
immunodeficiency virus; TST, tuberculin skin test.
a
Birth outside of the United States.
b
Analysis was limited to those with a reported TST result.
c
Analysis was limited to those with an abnormal chest radiograph finding.
d
Analysis was limited to those with a positive culture result and an isolate that had drug resistance results reported.
e
Numbers and percentages for HIV status do not include data for California or Vermont cases. California has not reported HIV data for TB cases 
since 2004 and, in earlier years, only reported cases as HIV infected or unknown; negative HIV test results were not reported. Vermont has not 
reported HIV data for TB cases since 2006.
f
Data were analyzed through 2005 to provide a 2-year period to complete reporting.
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TABLE 2
Characteristics of Patients with Tuberculosis (TB) among US-Born and Foreign-Born Healthcare Workers 
(HCWs) 18 Years of Age or Older, 1995–2007
HCWs with TB
(n = 6,049)
Characteristic US born(n = 2,736)
Foreign born
(n = 3,302)
Female sex 1,969 (72) 2,220 (67)
Mean/median age at diagnosis, years 43/43 39/37
Age at diagnosis range, years 18–91 18–87
Age group, years
 18–35 815 (30) 1,504 (46)
 36–54 1,352 (49) 1,417 (43)
 ≥55 569 (21) 381 (12)
Race/ethnicity
 Black, non-Hispanic 1,318 (48) 815 (25)
 White, non-Hispanic 1,060 (39) 194 (6)
 Hispanic 243 (9) 418 (13)
 Asian 58 (2) 1,836 (56)
 American Indian/Alaska Native 29 (1) 3 (<1)
 Native Hawaiian/Pacific Islander 14 (<1) 5 (<1)
 Unknown or multiple races 14 (<1) 31 (1)
TST result at time of TB diagnosisa 2,216 (81) 2,501 (76)
 Positive 1,855 (84) 2,315 (93)
 Negative 361 (16) 186 (7)
Culture positive for Mycobacterium tuberculosis 2,126 (78) 2,692 (82)
Site of disease
 Pulmonary TB only 1,917 (70) 1,883 (57)
 Extrapulmonary TB only 617 (23) 1,143 (35)
 Both pulmonary and extrapulmonary TB 200 (7) 276 (8)
Findings among patients with any pulmonary TB
 Positive acid-fast bacilli sputum smear result 861/2,117 (41) 836 (39)
 Positive cavitary chest radiograph findingsb 550/2,117 (26) 503 (23)
Drug resistancec 2,056 (75) 2,641 (80)
 Isoniazid monoresistance 130/2,056 (6) 331/2,641 (13)
 Multidrug resistance 35/2,056 (2) 54/2,641 (2)
HIV test result reportedd 1,678 (67) 1,649 (65)
 HIV positive 237/1,678 (14) 193/1,649 (12)
Refused HIV test 208 (8) 268 (8)
HIV test not offered, result unknown, or not reported 850 (31) 1,385 (42)
No previous diagnosis of TB 2,646 (97) 3,162 (96)
Postmortem diagnosis of TB 33 (1) 18 (<1)
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HCWs with TB
(n = 6,049)
Characteristic US born(n = 2,736)
Foreign born
(n = 3,302)
Excessive alcohol use 172 (6) 42 (1)
Injection or noninjection drug use 106 (4) 23 (1)
Incarceration at time of diagnosis 19 (1) 4 (<1)
Method of TB treatmente
 Directly observed therapy 955/2,457 (39) 835/2,710 (31)
 Self-administered therapy 856/2,457 (35) 1,202/2,710 (44)
 Both directly observed and self-administered therapy 595/2,457 (25) 642/2,710 (24)
 Unknown 51/2,457 (2) 31/2,710 (1)
Treatment outcomee
 Completed therapy 2,229/2,457 (91) 2,508/2,710 (93)
 Did not complete therapy 228/2,457 (9) 202/2,710 (7)
  Moved 27/2,457 (1) 71/2,710 (3)
  Lost to follow-up 26/2,457 (1) 36/2,710 (1)
  Died 86/2,457 (4) 46/2,710 (2)
  Uncooperative/refused 31/2,457 (1) 13/2,710 (<1)
  Other/unknown 58/2,457 (2) 36/2,710 (1)
NOTE. Data are no. (%) of persons with TB, unless otherwise indicated. Sum of percentages may not equal 100% due to rounding. HIV, human 
immunodeficiency virus; TST, tuberculin skin test.
a
Analysis was limited to those with a reported TST result.
b
Analysis was limited to those with an abnormal chest radiograph finding.
c
Analysis was limited to those with a positive culture result and an isolate that had drug resistance results reported.
d
Numbers and percentages for HIV status do not include data for California or Vermont cases. California has not reported HIV data for TB cases 
since 2004 and, in earlier years, only reported cases as HIV infected or unknown; negative HIV test results were not reported. Vermont has not 
reported HIV data for TB cases since 2006.
e
Data were analyzed through 2005 to provide a 2-year period to complete reporting.
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